SCHEMBL24687640

SCHEMBL24687640

COC[C@H](C)Nc1cnn(Cc2ccc(OC)cc2)c(=O)c1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 14/20 0.51
▸ MCHR1 Q99705 1/20 0.44
▸ PKM P14618 1/20 0.39
▸ PKLR P30613 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ RAF1 P04049 2/20 0.37
▸ CCNB2 O95067 1/20 0.37
▸ CCNE2 O96020 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ MET P08581 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ FGFR3 P22607 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24687647 0.92 NPBWR1 (0.49) NPBWR1MCHR1PKMPKLRBRD4
SCHEMBL24640479 0.90 NPBWR1 (0.51) NPBWR1MCHR1PKMPKLRBRD4
SCHEMBL21521225 0.90 NPBWR1 (0.51) NPBWR1MCHR1PKMPKLRBRD4
SCHEMBL21521227 0.90 NPBWR1 (0.51) NPBWR1MCHR1PKMPKLRBRD4
SCHEMBL30104870 0.90 NPBWR1 (0.46) NPBWR1MCHR1BRD4
SCHEMBL24962320 0.89 NPBWR1 (0.48) NPBWR1MCHR1PKMPKLRBRD4
SCHEMBL29153680 0.89 NPBWR1 (0.45) NPBWR1MCHR1BRD4
SCHEMBL29153679 0.89 NPBWR1 (0.45) NPBWR1MCHR1BRD4
SCHEMBL24687786 0.89 NPBWR1 (0.46) NPBWR1MCHR1PKMPKLRRAF1
SCHEMBL21522522 0.88 NPBWR1 (0.44) NPBWR1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022242750-A1 PIPERAZINE DERIVATIVE AND USE THEREOF IN MEDICINE 成都百裕制药股份有限公司 2022-11-24 — — WO disclosed
Send feedback